RECURRENT HEAD AND NECK CARCINOMA
Clinical trials for RECURRENT HEAD AND NECK CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEAD AND NECK CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT HEAD AND NECK CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise against tough cancers
Disease control CompletedThis study tested a combination of two drugs—sEphB4-HSA and pembrolizumab—in 42 people with advanced non-small cell lung cancer or head & neck cancer that had spread or returned. The goal was to see if the combo could shrink tumors better than standard treatments. Participants ha…
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Radioactive implants during surgery aim to stop head and neck Cancer's return
Disease control CompletedThis pilot study tested whether placing tiny radioactive seeds (Cesium-131) into the wound during surgery can kill leftover cancer cells in patients whose head and neck cancer has come back. Thirty adults with resectable tumors received the implant right after tumor removal. Rese…
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 26, 2026 19:05 UTC
-
Could a cancer pill before surgery help head and neck patients?
Disease control CompletedThis early-phase trial tested two doses of the drug erlotinib (Tarceva) given before surgery in 48 people with head and neck cancer. The goal was to see how the drug affects a protein called phospho-Akt in tumor samples. Researchers hope erlotinib might slow tumor growth by block…
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 13:40 UTC